Promise and Potential: Meeting Unmet Medical Needs through Regenerative Medicine
Regenerative medicine is uniquely capable of altering the fundamental mechanisms of disease. In the coming decades, regenerative medicine will play a paramount role in the delivery of clinical care. Gene therapy and cell therapy already on the market have demonstrated their value in treating patients with complications from diabetes, recovering from oral surgery, and those that need cartilage repair. But that’s the tip of the iceberg. These technologies are on the cusp of huge breakthroughs. There are hundreds of clinical trials ongoing for diseases such as heart disease, stroke, diabetes and HIV/AIDS; many of these are mid-to-late stage trials.
The briefing will provide an update on the latest advances moving forward in the field and address how The Regenerative Medicine Promotion Act can remove some of the hurdles facing the field of regenerative medicine.
Learn from Dr. Jakub Tolar, a Professor at the University of Minnesota in Pediatrics, Blood and Marrow Transplantation, and is also an attending physician at the University of Minnesota Masonic Children’s Hospital. Dr. Tolar was the Director of Stem Cell/Gene Therapies in the Division of Blood and Marrow Transplantation at the University of Minnesota from 2011-2013. In 2013, Dr. Tolar expanded his role within the University, becoming the Director of the Stem Cell Institute.
Learn from Edward Lanphier, the founder of Sangamo BioSciences, Inc. has served as President, Chief Executive Officer and as a member of the Board of Directors since Sangamo’s inception in 1995. He currently serves on the board of directors of the Biotechnology Institute, serves as incoming chair of the board of directors and as a member of the Executive Committee of the Alliance for Regenerative Medicine, the board of trustees for The Buck Institute for Research on Aging, and the Dean’s Advisory Board for the University of Michigan School of Public Health.
Please RSVP by Monday, November 10 to Miranda Franco at Miranda.email@example.com or 202-469-5259.